What is the best way to taper off fludrocortisone (mineralocorticoid)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fludrocortisone Tapering Protocol

The best way to taper fludrocortisone is through gradual dose reduction, decreasing by 0.025-0.05 mg increments every 1-2 weeks while monitoring for signs of mineralocorticoid deficiency. 1

Understanding Fludrocortisone

Fludrocortisone (Florinef) is a synthetic mineralocorticoid used primarily in:

  • Primary adrenal insufficiency (Addison's disease)
  • Salt-losing forms of congenital adrenal hyperplasia
  • Severe hypotension requiring plasma volume restoration 2

The typical maintenance dose ranges from 0.05-0.2 mg daily, taken as a single oral dose in the morning 1, 3.

Tapering Protocol

Step 1: Assess Readiness for Tapering

  • Ensure patient is clinically stable with normal electrolytes
  • Verify no recent episodes of adrenal crisis
  • Confirm patient is not experiencing acute illness or significant physical stress

Step 2: Gradual Dose Reduction

  1. Reduce dose by 0.025-0.05 mg every 1-2 weeks
  2. For patients on higher doses (>0.1 mg daily), initial reductions can be slightly larger
  3. As you approach lower doses (<0.05 mg daily), slow the taper further with smaller increments

Step 3: Monitoring During Taper

Monitor for signs of mineralocorticoid deficiency 1, 3:

  • Blood pressure (especially orthostatic changes)
  • Serum electrolytes (sodium and potassium)
  • Plasma renin activity (PRA) - aim for upper normal range
  • Clinical symptoms:
    • Lightheadedness
    • Salt cravings
    • Fatigue
    • Weakness

Step 4: Adjustments Based on Response

  • If signs of mineralocorticoid deficiency appear, return to previous effective dose
  • Allow 1-2 weeks at stable dose before attempting further reductions
  • Consider slower tapering in patients with long-term use

Special Considerations

Complete Discontinuation vs Maintenance

  • Complete discontinuation is only appropriate if fludrocortisone was prescribed for a temporary condition
  • Patients with primary adrenal insufficiency will likely require lifelong mineralocorticoid replacement 1

Medication Interactions

Avoid these medications during tapering as they may interact with fludrocortisone 1:

  • Diuretics
  • NSAIDs
  • Acetazolamide
  • Carbenoxolone/licorice
  • Drospirenone-containing contraceptives

Stress Dosing

Unlike glucocorticoids, fludrocortisone typically does not require stress dosing during illness or surgery 1.

Pitfalls to Avoid

  1. Tapering too rapidly: This can precipitate mineralocorticoid deficiency with hypotension, hyperkalemia, and hyponatremia 3

  2. Ignoring electrolyte changes: Regular monitoring of sodium and potassium is essential during the tapering process

  3. Failing to distinguish between glucocorticoid and mineralocorticoid effects: Fludrocortisone tapering should be managed separately from any concurrent glucocorticoid tapering 1

  4. Overlooking orthostatic hypotension: Check blood pressure in both supine and standing positions during tapering

  5. Discontinuing abruptly: This can lead to acute mineralocorticoid deficiency, especially in patients with primary adrenal insufficiency 3

Remember that unlike glucocorticoid tapering, which often focuses on hypothalamic-pituitary-adrenal axis recovery, mineralocorticoid tapering is primarily concerned with maintaining electrolyte balance and adequate blood pressure 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Synthetic mineralocorticoid].

Nihon rinsho. Japanese journal of clinical medicine, 2008

Research

Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.

Best practice & research. Clinical endocrinology & metabolism, 2015

Research

The Glucocorticoid Taper: A Primer for the Clinicians.

Indian journal of endocrinology and metabolism, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.